June 2026 Quarterly Activities Report and Appendix 4C
Filed with ASX · · 12 pages · English
Summary by 6ix AI
Additionally, early results from a depression treatment program show promising improvements in patient outcomes, supporting Emyria's strategy for scaling advanced mental health treatments. The company reported a notable increase in quarterly revenue, reflecting continued growth in clinic operations and patient demand.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Emyria
- Emyria Depression Program Shows Positive Results
- Emyria Confirms NSW Workforce Ahead of Clinic Opening
- Emyria Company Update Presentation
- TGA Update to Accelerate Empax Therapist Recruitment
- Emyria Activates First Victorian Empax Clinic
Later from Emyria
- Emyria Unlocks Treatment Capacity
- Appendix 4E & Annual Financial Report Year End 30 June 2026
- Emyria Set to Launch First NSW Clinic
- FDA Selects EMD to Present at Psychedelic Medicines Hearing
- Emyria Successfully Opens First NSW Empax Clinic
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria